ANNUAL ERADICATION RATE OF BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI INFECTION: A 15-YEAR PROSPECTIVE STUDY AT A TERTIARY HOSPITAL IN KOREA

被引：0
|
作者：
Kim, Nayoung
Yoon, Kichul
Lee, Dong Ho
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1379
引用
收藏
页码：S571 / S571
页数：1
相关论文
共 50 条
  • [31] Comparison of the traditional triple and a new bismuth-containing quadruple therapy in the first-line eradication of Helicobacter pylori
    Varga Mate
    Dracz Lajos
    Kolbenheyer Erik
    Varga Ferenc
    Patai Arpad, V
    Solymosi Norbert
    Patai Arpad
    ORVOSI HETILAP, 2019, 160 (34) : 1340 - 1345
  • [32] Helicobacter pylori Eradication Rates and Related Factors by Second-Line Bismuth-Based Quadruple Therapy
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Lee, Jun Yeob
    Lee, Jin Wook
    Kim, Hae Koo
    Nam, Kyoung Sik
    Nam, Yong Jin
    GASTROENTEROLOGY, 2016, 150 (04) : S881 - S881
  • [33] Trend of First-Line and Second-Line Eradication Therapy for Helicobacter pylori Infection in Korea
    Chung, Jun-Won
    Jung, Hwoon-Yong
    Choi, Kee Don
    Song, Ho June
    Choi, Kwi-Sook
    Jung, Kee Wook
    Lee, Gin Hyug
    Kim, Do Hoon
    Kim, Jin-Ho
    GASTROENTEROLOGY, 2009, 136 (05) : A24 - A24
  • [34] TREND IN HELICOBACTER PYLORI ERADICATION RATES BY SECOND-LINE BISMUTH-BASED QUADRUPLE THERAPY AND RELATED FACTORS IN ERADICATION THERAPY
    Kim, S.
    Park, M.
    Park, S.
    Moon, W.
    Park, S.
    Jo, J.
    Kim, S.
    HELICOBACTER, 2015, 20 : 94 - 94
  • [35] Helicobacter pylori First-Line Treatment With Bismuth-Containing Quadruple Therapy, and Second-Line Levofloxacin-Based Rescue Option, in Patients Allergic to Penicillin
    Gisbert, Javier P.
    Barrio, Jesus
    Modolell, Ines
    Molina-Infante, Javier
    Aisa, Angeles Perez
    Gisbert, JoseLuis
    Bermejo, Miguel Fernandez
    Marcos, Santiago
    GASTROENTEROLOGY, 2014, 146 (05) : S393 - S393
  • [36] HELICOBACTER PYLORI FIRST-LINE TREATMENT WITH BISMUTH-CONTAINING QUADRUPLE THERAPY, AND SECOND-LINE LEVOFLOXACIN-BASED RESCUE OPTION, IN PATIENTS ALLERGIC TO PENICILLIN
    Gisbert, J. P.
    Barrio, J.
    Modolell, I.
    Molina-Infante, J.
    Perez-Aisa, A.
    Gisbert, J. L.
    Fernandez-Bermejo, M.
    Marcos, S.
    HELICOBACTER, 2013, 18 : 132 - 132
  • [37] Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea
    Moon, Ji Yoon
    Kim, Gwang Ha
    You, Hyun Seok
    Lee, Bong Eun
    Ryu, Dong Yeop
    Cheong, Jae Hoon
    Jung, Jung Im
    Jeong, Jae Hoon
    Song, Chul Soo
    Song, Geun Am
    GUT AND LIVER, 2013, 7 (04) : 406 - 410
  • [38] LEVOFLOXACIN, METRONIDAZOLE, AND LANSOPRAZOLE TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY AS A SECOND-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION IN KOREA
    Kim, G.
    Lee, B.
    Lee, H.
    Song, G.
    Seol, S.
    HELICOBACTER, 2013, 18 : 126 - 126
  • [39] Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy
    Kim, Min Soo
    Kim, Nayoung
    Kim, Sung Eun
    Jo, Hyun Jin
    Shin, Cheol Min
    Park, Young Soo
    Lee, Dong Ho
    BMC GASTROENTEROLOGY, 2013, 13
  • [40] Long-Term Follow up Helicobacter pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy
    Kim, Nayoung
    Kim, Min Soo
    Nam, Ryoung Hee
    Choi, Mi Ji
    Jo, Hyun Jin
    Shin, Cheol Min
    Lee, Dong Ho
    GASTROENTEROLOGY, 2013, 144 (05) : S335 - S335
12345